Search results for "type 2"

showing 10 items of 1034 documents

Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?

2019

Since mitochondrial dysfunction is associated with NOD-like receptor family protein 3 (NLRP3) activation in type 2 diabetes (T2D), which can eventually lead to an impaired immune response, we set out to determine if glycemic control modulates the effects of T2D on the NLRP3 inflammasome. We have studied leukocytes from 61 diabetic patients [25 with glycated hemoglobin (HbA(1c)) 7% and 36 with HbA(1c) 8%] and 40 healthy controls. Total and mitochondrial reactive oxygen species (ROS) production was enhanced in T2D patients, and mitochondrial ROS was more pronounced in those with poor glycemic control. Levels of gene and protein expression of NLRP3 were decreased in both diabetic groups and mo…

Blood GlucoseMale0301 basic medicineMitochondrial ROSendocrine system diseasesInflammasomesPhysiologyClinical BiochemistryType 2 diabetesmedicine.disease_causeBiochemistrychemistry.chemical_compoundGene expressionoxidative stressGeneral Environmental Scienceintegumentary systemInterleukinInflammasomeMiddle AgedMitochondriaglycaemic controlCytokinesFemaletype 2 diabetesInflammation MediatorsSignal Transductionmedicine.drugmedicine.medical_specialty03 medical and health sciencesmitochondrial functionInternal medicineNLR Family Pyrin Domain-Containing 3 ProteinmedicineHumansBody Weights and MeasuresMolecular BiologyAgedGlycemicGlycated Hemoglobin030102 biochemistry & molecular biologybusiness.industrynutritional and metabolic diseasesCell Biologymedicine.diseaseNLRP3 inflammasome030104 developmental biologyEndocrinologyDiabetes Mellitus Type 2chemistryGeneral Earth and Planetary SciencesGlycated hemoglobinReactive Oxygen SpeciesbusinessBiomarkersOxidative stressAntioxidants & Redox Signaling
researchProduct

Chronological Age Interacts with the Circadian Melatonin Receptor 1B Gene Variation, Determining Fasting Glucose Concentrations in Mediterranean Popu…

2020

Gene-age interactions have not been systematically investigated on metabolic phenotypes and this modulation will be key for a better understanding of the temporal regulation in nutrigenomics. Taking into account that aging is typically associated with both impairment of the circadian system and a decrease in melatonin secretion, we focused on the melatonin receptor 1B (MTNR1B)-rs10830963 C&gt

Blood GlucoseMale0301 basic medicinePhysiologyType 2 diabetestype-2 diabetesDiabetis no-insulinodependentMediterranean population0302 clinical medicineRisk FactorsPolymorphism (computer science)MedicineNon-insulin-dependent diabetesmelatonin receptorAged 80 and overeducation.field_of_studyNutrition and DieteticsMediterranean RegionAge FactorsDiabetis en l'embaràsFastingMiddle AgedGestational diabetesMTNR1B polymorphismCohortFemalepregnancywomengestational diabeteslcsh:Nutrition. Foods and food supplyage-interactionhormones hormone substitutes and hormone antagonistsAdultDiabetes riskAdolescentPopulationlcsh:TX341-641030209 endocrinology & metabolismPolymorphism Single NucleotideRisk AssessmentArticleYoung Adult03 medical and health sciencesDiabetes mellitusHumanseducationAgedRetrospective StudiesReceptor Melatonin MT2business.industrymedicine.diseaseCross-Sectional Studies030104 developmental biologyDiabetes Mellitus Type 2Melatonin receptor 1BSpainheterogeneitybusinessDiabetes in pregnancyfasting glucoseFood ScienceNutrients
researchProduct

Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia

2018

Aims/hypotheses We hypothesized that there is decreased synthesis of glutathione (GSH) in type 2 diabetes (T2DM) especially in the presence of microvascular complications, and this is dependent on the degree of hyperglycemia. Methods In this case-control study, we recruited 16 patients with T2DM (7 without and 9 with microvascular complications), and 8 age- and sex-matched non-diabetic controls. We measured GSH synthesis rate using an infusion of [2H2]-glycine as isotopic tracer and collection of blood samples for liquid chromatography mass spectrometric analysis. Results Compared to the controls, T2DM patients had lower erythrocyte GSH concentrations (0.90 ± 0.42 vs. 0.35 ± 0.30 mmol/L; P …

Blood GlucoseMale0301 basic medicinelcsh:MedicineType 2 diabetesmedicine.disease_causeBiochemistrychemistry.chemical_compoundEndocrinology0302 clinical medicineGlucose MetabolismAnimal CellsRed Blood CellsMedicine and Health SciencesDiabetes diagnosis and managementMedicineAmino Acidslcsh:ScienceMultidisciplinaryOrganic CompoundsMiddle AgedGlutathioneMass spectrometricType 2 DiabetesChemistryPhysical SciencesCarbohydrate MetabolismFemaleCellular TypesResearch ArticleAdultGlutathione metabolismmedicine.medical_specialtyHbA1cEndocrine DisordersGlycine030209 endocrinology & metabolism03 medical and health sciencesDiabetes mellitusInternal medicineMoleDiabetes MellitusHumansHemoglobinBlood Cellsbusiness.industrylcsh:ROrganic ChemistryChemical CompoundsCase-control studyBiology and Life SciencesProteinsCell BiologyGlutathionemedicine.diseaseDiagnostic medicineOxidative StressMetabolism030104 developmental biologyEndocrinologyAliphatic Amino AcidsDiabetes Mellitus Type 2chemistryMetabolic DisordersCase-Control StudiesMicrovesselslcsh:QPeptidesbusinessDiabetic AngiopathiesOxidative stressPLOS ONE
researchProduct

In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters

2016

Backgrounds and aims: Low concentrations of plasma HDL-C are associated with the development of atherosclerotic cardiovascular diseases and type 2 diabetes. Here we aimed to explore the relationship between the in vivo fractional synthesis of triglycerides (fTG) in subcutaneous (s.q.) abdominal adipose tissue (AT), HDL-C concentrations and HDL particle size composition in non-diabetic humans. Methods: The fTG in s.q. abdominal AT was measured in 16 non-diabetic volunteers (7 women, 9 men; Age: 49 ± 20 years; BMI: 31 ± 5 kg/m; Fasting Plasma Glucose: 90 ± 10 mg/dl) after 2H2O labeling. HDL-C concentration and subclasses, large (L-HDL), intermediate (I-HDL) and small (S-HDL) were measured. Re…

Blood GlucoseMale0301 basic medicinemedicine.medical_specialtyAdipocyte; Atheroprotective; Gender-related; HDL-C metabolism; Mass spectrometry; Stable isotope tracer kinetics; Triglycerides; Cardiology and Cardiovascular MedicineAdipose tissueWhite adipose tissueType 2 diabetes030204 cardiovascular system & hematologyTriglycerideArticleAtheroprotective03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceIn vivoInternal medicineAdipocytemedicineHumansObesityTriglyceridesAgedHDL-C metabolismAdipocyteStable isotope tracer kineticMass spectrometrybusiness.industryLipogenesisCholesterol HDLnutritional and metabolic diseasesMiddle AgedAtherosclerosismedicine.diseaseLipidsObesitySubcutaneous Fat AbdominalGender-related030104 developmental biologyEndocrinologychemistryLipogenesisFemalelipids (amino acids peptides and proteins)Insulin ResistanceCardiology and Cardiovascular MedicinebusinessAtherosclerosis
researchProduct

Serum Dehydroepiandrosterone Sulfate and Risk for Type 2 Diabetes in Older Men and Women: The Pro.V.A Study

2016

Objective: A large body of clinical data suggests the importance of endogenous sex hormones in the pathogenesis of diabetes, but very little is known about the possible relationship between dehydroepiandrosterone sulfate (DHEAS) and diabetes, particularly in the elderly. We aimed, therefore, to examine whether high serum levels of DHEAS have any protective effects on the incidence of type 2 diabetes and to elucidate the possible role of gender in a cohort of older subjects. Methods: We followed 1258 community-dwelling subjects aged ≥65 years without type 2 diabetes who belonged to the Progetto Veneto Anziani (Pro.V.A.) for 4.4±1.2 years. DHEAS were measured at baseline and categorized into …

Blood GlucoseMale0301 basic medicinemedicine.medical_specialtyDHEASEndocrinology Diabetes and MetabolismBlood sugarPhysiology030209 endocrinology & metabolismType 2 diabetesNOsex hormones in the pathogenesis of diabeteCohort Studies03 medical and health scienceschemistry.chemical_compoundElderly0302 clinical medicineEndocrinologyDehydroepiandrosterone sulfateRisk FactorsInternal medicineDiabetes mellitusInternal MedicineHumansMedicineAgedGlycated HemoglobinDehydroepiandrosterone Sulfatebusiness.industryIncidence (epidemiology)Type 2 diabetesGeneral MedicinePrognosismedicine.diseaseCommunity-dwelling adultsDiabetes and Metabolism030104 developmental biologyEndocrinologyDiabetes Mellitus Type 2chemistrydehydroepiandrosterone sulfate (DHEAS)CohortCommunity-dwelling adults; DHEAS; Elderly; Type 2 diabetes; Internal Medicine; Endocrinology; Endocrinology Diabetes and MetabolismFemaleGlycated hemoglobinbusinessBiomarkersFollow-Up StudiesCohort studyCanadian Journal of Diabetes
researchProduct

Glucose regulation and grip strength in adults: Findings from the Helsinki Birth Cohort Study.

2021

Aim: this study aimed to assess the association between grip strength and glucose regulation in a cross-sectional setting.Methods: using data from the Helsinki Birth Cohort Study, 924 men and 953 women were studied at a mean age of 61.6 years. Grip strength was assessed in the dominant hand using a Newtest Grip Force dynamometer. A standard 2-h 75 g oral glucose tolerance test (OGTT) was used to define glucose regulation. The participants were classified into four groups: normoglycaemia, prediabetes (impaired fasting glucose or impaired glucose tolerance), newly diagnosed diabetes and previously known diabetes. The association between grip strength and glucose regulation was assessed using …

Blood GlucoseMaleAgingHealth (social science)EpidemiologyPhysical fitnesspuristusvoimaprediabetesImpaired glucose toleranceCohort StudiesMUSCLE STRENGTHGrip strengthDiabetes mellitus0302 clinical medicine030212 general & internal medicinePrediabetesepidemiologiakohorttitutkimusRISK2. Zero hungerdiabetesHand Strength3. Good healthfyysinen kuntodiabetes mellitusepidemiologyFemaleHEALTHmedicine.medical_specialtyPrediabetic State03 medical and health sciencesAGEDiabetes mellitusInternal medicinemedicineHumansOLDER-ADULTS030214 geriatricsbusiness.industryDIABETES-MELLITUSPhysical fitnessmedicine.diseaseImpaired fasting glucoseikääntyminenPHYSICAL-ACTIVITYCross-Sectional StudiesGlucoseDiabetes Mellitus Type 2Grip strengthMOBILITYgrip strength3121 General medicine internal medicine and other clinical medicinephysical fitnessBlood sugar regulationGeriatrics and GerontologybusinessPrediabetesGerontologyBody mass indexArchives of gerontology and geriatrics
researchProduct

Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and de…

2015

Abstract Objectives Severe hypoglycemia is associated with cognitive decline and dementia in older persons with type 2 diabetes. The role of antidiabetic treatments on severe hypoglycemia is unknown in dementia. The aims were to determine the prevalence of severe hypoglycemic events and investigate associations among severe hypoglycemic and specific antidiabetic treatments (classes of oral agents and types of insulin analogs) in a large sample of nursing home patients with diabetes according to dementia status. Design Cross-sectional observational study. Setting A total of 150 nursing homes across Italy. Participants A total of 2258 patients with type 2 diabetes (dementia = 1138, no dementi…

Blood GlucoseMaleAgingSevere hypoglycemia dementia insulin analogs antidiabetic oral agents agingmedicine.medical_treatmentInsulin analogAdministration OralType 2 diabetesSeverity of Illness IndexInsulin AntagonistsReference ValuesOdds RatioPrevalenceHomes for the AgedInsulinReference ValueCognitive declineNursing (all)2901 Nursing (miscellaneous)General NursingAged 80 and overInsulin AntagonistMedicine (all)Health PolicyAging; Antidiabetic oral agents; Dementia; Insulin analogs; Severe hypoglycemia; Administration Oral; Age Distribution; Aged; Aged 80 and over; Blood Glucose; Confidence Intervals; Cross-Sectional Studies; Dementia; Diabetes Mellitus Type 2; Female; Homes for the Aged; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Antagonists; Italy; Logistic Models; Male; Middle Aged; Nursing Homes; Odds Ratio; Prevalence; Prognosis; Reference Values; Risk Assessment; Severity of Illness Index; Sex Distribution; Sulfonylurea Compounds; Nursing (all)2901 Nursing (miscellaneous); Health PolicyGeneral MedicineMiddle AgedPrognosisSulfonylurea CompoundNursing HomeItalyFemaleHumanmedicine.medical_specialtyLogistic ModelPrognosiHypoglycemiaelderly patientsRisk AssessmentAge DistributionInternal medicineDiabetes mellitusmedicineConfidence IntervalsDementiaHumansHypoglycemic AgentsSex DistributionAgedAntidiabetic oral agentCross-Sectional StudieSevere hypoglycemiaHypoglycemic Agentbusiness.industryInsulinOdds ratiomedicine.diseaseHypoglycemiaNursing HomesEndocrinologyCross-Sectional StudiesLogistic ModelsSulfonylurea CompoundsDiabetes Mellitus Type 2DementiaGeriatrics and GerontologybusinessConfidence IntervalBody mass indexJournal of the American Medical Directors Association
researchProduct

Persistence of the effect of birth size on dysglycaemia and type 2 diabetes in old age: AGES-Reykjavik Study

2012

We studied the effect of birth size on glucose and insulin metabolism among old non-diabetic individuals. We also explored the combined effect of birth size and midlife body mass index (BMI) on type 2 diabetes in old age. Our study comprised 1,682 Icelanders whose birth records included anthropometrical data. The same individuals had participated in the prospective population-based Reykjavik Study, where BMI was assessed at a mean age of 47 years, and in the AGES-Reykjavik Study during 2002 to 2006, where fasting glucose, insulin and HbA₁c were measured and homeostasis model assessment for the degree of insulin resistance (HOMA-IR) calculated at a mean age of 75.5 years. Type 2 diabetes was…

Blood GlucoseMaleAgingmedicine.medical_specialtyPediatricsBirth weightPopulationIcelandType 2 diabetesWeight GainArticleBody Mass IndexInsulin resistanceDiabetes mellitusInternal medicinemedicineBirth WeightHumansInsulinsyntymäpainoProspective StudieseducationAgedAged 80 and overGlucose tolerance testeducation.field_of_studydiabetesmedicine.diagnostic_testbusiness.industryIncidenceagingGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseLow birth weightikääntyminenEndocrinologyDiabetes Mellitus Type 2Population SurveillanceDisease ProgressionFemaleInsulin ResistanceGeriatrics and Gerontologymedicine.symptombusinessBody mass indexbirth sizeFollow-Up StudiesAGE
researchProduct

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular …

2012

Abstract Background and aims Metformin is the first-line therapy in type 2 diabetes. In patients inadequately controlled with metformin, the addition of a sulfonylurea or pioglitazone are equally plausible options to improve glycemic control. However, these drugs have profound differences in their mechanism of action, side effects, and impact on cardiovascular risk factors. A formal comparison of these two therapies in terms of cardiovascular morbidity and mortality is lacking. The TOSCA.IT study was designed to explore the effects of adding pioglitazone or a sulfonylurea on cardiovascular events in type 2 diabetic patients inadequately controlled with metformin. Methods Multicentre, random…

Blood GlucoseMaleBIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICAEndocrinology Diabetes and Metabolismpioglitazone sulfonylurea type 2 diabetes metformin cardiovascular eventsMedicine (miscellaneous)Type 2 diabetesSettore MED/13 - EndocrinologiaBody Mass Indexlaw.inventionRandomized controlled trialRisk FactorslawSurveys and QuestionnairesCardiovascular DiseasepioglitazonepiogllitazoneStrokeDiabetes Therapy PioglitazoneNutrition and DieteticsDiabetesThiazolidinedionecardiovascular events; pioglitazone; Type 2 Diabetes Mellitus; sulphonylureasType 2 diabetesMiddle AgedMetforminSulfonylurea CompoundTreatment OutcomeTolerabilitysulphonylureasCardiovascular DiseasesDrug Therapy CombinationFemaletype 2 diabetesCardiology and Cardiovascular MedicineHumanmedicine.drugmedicine.medical_specialtyEndpoint Determinationsulfonylureacardiovascualr eventSudden deathFollow-Up Studiecardiovascular eventsInternal medicineDiabetes mellitusmedicineHumansHypoglycemic Agentssulfonylureasinterventio trialtype 2 diabetes; cardiovascular events; pioglitazone; sulfonylureas; randomized controlled trialAgedHypoglycemic AgentQuestionnairebusiness.industryRisk Factormedicine.diseaseSurgeryType 2 Diabetes MellitusSulfonylurea CompoundsDiabetes Mellitus Type 2randomized controlled trialQuality of LifeThiazolidinedionesTherapybusinessmetforminPioglitazoneFollow-Up Studies
researchProduct

Physical Inactivity from Youth to Adulthood and Risk of Impaired Glucose Metabolism

2018

Introduction: Physical activity (PA) is important in the prevention and treatment of impaired glucose metabolism. However, association of physical inactivity during the transition between childhood and adulthood with glucose metabolism is unknown. Therefore, we studied the association of persistent physical inactivity since childhood with glucose metabolism in adulthood. Methods: Data were drawn from the ongoing, Cardiovascular Risk in Young Finns Study with repeated follow-ups between 1980 and 2011 (baseline age, 3-18 yr; n = 3596). Impaired glucose metabolism was defined as having impaired fasting glucose (6.1-6.9 mmol·L-1) or type 2 diabetes in adulthood. Leisure-time PA habits were repe…

Blood GlucoseMaleCross-sectional studyphysical activityType 2 diabetes030204 cardiovascular system & hematology0302 clinical medicineRisk FactorsSurveys and QuestionnairesOrthopedics and Sports MedicineLongitudinal Studies030212 general & internal medicineta315impaired glucose metabolismChildFinlandliikkumattomuusta3142Middle AgedaikuisuusChild PreschoolFemalefyysinen aktiivisuusAdultmedicine.medical_specialtyAdolescentPhysical Therapy Sports Therapy and RehabilitationpitkittäistutkimusCarbohydrate metabolism03 medical and health sciencesaineenvaihduntahäiriötInternal medicineDiabetes mellitusmedicineHumansExerciseLife Stylechildhoodbusiness.industryMetabolismlapsuusta3121medicine.diseaseImpaired fasting glucoseConfidence intervalCross-Sectional StudiesGlucoseEndocrinologyDiabetes Mellitus Type 2Relative riskphysical inactivitySedentary Behaviorbusinessaikuistyypin diabetesMedicine & Science in Sports & Exercise
researchProduct